{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T13:27:00Z","timestamp":1774445220729,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong Administration of Traditional Chinese Medicine Research Foundation","award":["20241364"],"award-info":[{"award-number":["20241364"]}]},{"name":"Guangdong Administration of Traditional Chinese Medicine Research Foundation","award":["20231378"],"award-info":[{"award-number":["20231378"]}]},{"name":"Guangdong Administration of Traditional Chinese Medicine Research Foundation","award":["20261457"],"award-info":[{"award-number":["20261457"]}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2023305"],"award-info":[{"award-number":["A2023305"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515220014"],"award-info":[{"award-number":["2023A1515220014"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangmen Planned Project of Science and Technology","award":["2320002000781"],"award-info":[{"award-number":["2320002000781"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11722-0","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:48:55Z","timestamp":1774435735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the USP7-PGAM5 axis overcomes oxaliplatin resistance in colorectal cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Chengxing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canxiu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaorong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoming","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"11722_CR1","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 71(3):209\u2013249","DOI":"10.3322\/caac.21660"},{"key":"11722_CR2","doi-asserted-by":"crossref","unstructured":"Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V (2020) 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future, 206. Pharmacology & Therapeutics, p 107447","DOI":"10.1016\/j.pharmthera.2019.107447"},{"issue":"15","key":"11722_CR3","first-page":"1193","volume":"42","author":"L Zhang","year":"2023","unstructured":"Zhang L, Wang Y, Li C, Wang J, Chen X, Liu Z, Zhao H, Wu K (2023) RNF43 suppresses colorectal cancer stemness and tumorigenesis by ubiquitinating and degrading SOX9. Oncogene 42(15):1193\u20131205","journal-title":"Oncogene"},{"issue":"1","key":"11722_CR4","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z, Ding X, Bao R, Hong L, Jia W, Fang F, Liu H, Chen L, Zhong J, Zou D, Liu L, Han L, Ginhoux F, Liu Y, Ye Y, Su B (2022) Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1\u2009+\u2009macrophages in colorectal cancer. Nat Commun 13(1):1742","journal-title":"Nat Commun"},{"issue":"5","key":"11722_CR5","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2(5):e1600200","journal-title":"Sci Adv"},{"issue":"2","key":"11722_CR6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/cancers13020263","volume":"13","author":"M Certo","year":"2021","unstructured":"Certo M, Tsai CH, Pucino V, Ho PC, Mauro C (2021) Lactate modulation of immune responses in inflammatory and tumor microenvironments. Cancers 13(2):263","journal-title":"Cancers"},{"issue":"1","key":"11722_CR7","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q (2021) Inference and analysis of cell-cell communication using CellChat. Nat Commun 12(1):1088","journal-title":"Nat Commun"},{"key":"11722_CR8","first-page":"215611","volume":"534","author":"M Li","year":"2022","unstructured":"Li M, Xu R, Zhou H, Wang S, Zhang T, Sang J, Li J (2022) PGAM5 reprograms glycolytic metabolism and promotes 5-FU resistance in colorectal cancer through regulation of the HK2-PDHA1 axis. Cancer Lett 534:215611","journal-title":"Cancer Lett"},{"key":"11722_CR9","first-page":"104232","volume":"193","author":"A Morrot","year":"2025","unstructured":"Morrot A, da Silva APD (2025) Targeting O-GlcNAcylation in tumor-associated inflammation: from molecular mechanisms to cancer therapy. Crit Rev Oncol\/Hematol 193:104232","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"4","key":"11722_CR10","first-page":"456","volume":"13","author":"T Altendorfer-Kroath","year":"2025","unstructured":"Altendorfer-Kroath T, Schimek V, Riedl R, Stangl H, Zatloukal K, Poteser M, Willingseder D, Hekl D, Schreibmayer W (2025) Utilizing cOFM living models to dynamically track metabolic evolution of glioblastoma and its interaction with tumor microenvironment. Neurooncology 13(4):456\u2013467","journal-title":"Neurooncology"},{"issue":"15","key":"11722_CR11","first-page":"2197","volume":"41","author":"Y Li","year":"2022","unstructured":"Li Y, Wang Y, Zhang Z, Liu J, Li P, Xu K, Chen W (2022) USP7 deubiquitinates and stabilizes \u03b2-catenin to promote colorectal cancer cell proliferation. Oncogene 41(15):2197\u20132208","journal-title":"Oncogene"},{"issue":"1","key":"11722_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41392-023-01328-4","volume":"8","author":"X Chen","year":"2023","unstructured":"Chen X, Qiu W, Zhang Y, Wang J, Li H, Lin Y, Lu Z (2023) Phosphoglycerate mutase family member 5 (PGAM5): a key regulator of mitochondrial dynamics in health and disease. Signal Transduct Target Therapy 8(1):45","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"11722_CR13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-024-06477-0","volume":"15","author":"F Wang","year":"2024","unstructured":"Wang F, Cheng Y, Zhang X, Li M, Zhao K, He R, Zhang L (2024) The E3 ubiquitin ligase TRIM21 regulates PGAM5 stability to mediate cardiomyocyte death. Cell Death Dis 15(1):88","journal-title":"Cell Death Dis"},{"issue":"5","key":"11722_CR14","first-page":"728","volume":"25","author":"R Liu","year":"2023","unstructured":"Liu R, Wang B, Zhang M, Li S, Chen H, Zhou A, Tan M (2023) PGAM5 coordinates mitochondrial fission and mitophagy by recruiting Drp1 to mitochondria. Nat Cell Biol 25(5):728\u2013740","journal-title":"Nat Cell Biol"},{"issue":"6","key":"11722_CR15","first-page":"891","volume":"84","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li Q, Wang J, Zhang L, Feng Y, Li X, Gao J (2024) PGAM5-mediated regulation of mitochondrial dynamics promotes the progression of non-small cell lung cancer and confers chemoresistance. Cancer Res 84(6):891\u2013904","journal-title":"Cancer Res"},{"issue":"1","key":"11722_CR16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-023-01810-1","volume":"22","author":"J Xu","year":"2023","unstructured":"Xu J, Chen Y, Li W, Wang X, Liu Q, Zhang D, Pan Y (2023) Targeting PGAM5 to overcome apoptosis resistance in solid tumors: mechanisms and therapeutic implications. Mol Cancer 22(1):102","journal-title":"Mol Cancer"},{"key":"11722_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bcp.2017.02.011","volume":"131","author":"T An","year":"2017","unstructured":"An T, Gong Y, Li X, Kong L, Ma P, Gong L et al (2017) USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth. Biochem Pharmacol 131:29\u201339","journal-title":"Biochem Pharmacol"},{"key":"11722_CR18","doi-asserted-by":"crossref","unstructured":"Park HB, Baek KH (2023) Current and future directions of USP7 interactome in cancer study. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(4):188992","DOI":"10.1016\/j.bbcan.2023.188992"},{"issue":"1","key":"11722_CR19","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z et al (2022) Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1\u2009+\u2009macrophages in colorectal cancer. Nat Commun 13(1):1742","journal-title":"Nat Commun"},{"key":"11722_CR20","doi-asserted-by":"crossref","unstructured":"Kumar S, Basu M, Ghosh MK (2024) E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(8):119827","DOI":"10.1016\/j.bbamcr.2024.119827"},{"issue":"20","key":"11722_CR21","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.3390\/molecules30204038","volume":"30","author":"PMC Disclaimer | PMC Copyright Notice","year":"2025","unstructured":"PMC Disclaimer | PMC Copyright Notice (2025) USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis. Molecules 30(20):4038","journal-title":"Molecules"},{"issue":"15","key":"11722_CR22","first-page":"2197","volume":"41","author":"Y Li","year":"2022","unstructured":"Li Y, Wang Y, Zhang Z, Liu J, Li P, Xu K et al (2022) USP7 deubiquitinates and stabilizes \u03b2-catenin to promote colorectal cancer cell proliferation. Oncogene 41(15):2197\u20132208","journal-title":"Oncogene"},{"issue":"6","key":"11722_CR23","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1007\/s10565-023-09822-9","volume":"39","author":"Y Chang","year":"2023","unstructured":"Chang Y et al (2023) USP7-mediated JUND suppresses RCAN2 transcription and elevates NFATC1 to enhance stem cell property in colorectal cancer. Cell Biol Toxicol 39(6):3121\u20133140","journal-title":"Cell Biol Toxicol"},{"key":"11722_CR24","doi-asserted-by":"publisher","first-page":"1427663","DOI":"10.3389\/fonc.2024.1427663","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Pan J, Zheng P (2024) USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53. Front Oncol 14:1427663","journal-title":"Front Oncol"},{"issue":"2","key":"11722_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.stemcr.2022.12.013","volume":"18","author":"L Novellasdemunt","year":"2023","unstructured":"Novellasdemunt L, Kucharska A, Baulies A, Vlachogiannis G, Repana D, Rowan A et al (2023) USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor development. Stem Cell Rep 18(2):570\u2013584","journal-title":"Stem Cell Rep"},{"issue":"5","key":"11722_CR26","first-page":"728","volume":"25","author":"R Liu","year":"2023","unstructured":"Liu R, Wang B, Zhang M, Li S, Chen H, Zhou A et al (2023) PGAM5 coordinates mitochondrial fission and mitophagy by recruiting Drp1 to mitochondria. Nat Cell Biol 25(5):728\u2013740","journal-title":"Nat Cell Biol"},{"issue":"6","key":"11722_CR27","first-page":"891","volume":"84","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li Q, Wang J, Zhang L, Feng Y, Li X et al (2024) PGAM5-mediated regulation of mitochondrial dynamics promotes the progression of non-small cell lung cancer and confers chemoresistance. Cancer Res 84(6):891\u2013904","journal-title":"Cancer Res"},{"issue":"1","key":"11722_CR28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-024-06477-0","volume":"15","author":"F Wang","year":"2024","unstructured":"Wang F, Cheng Y, Zhang X, Li M, Zhao K, He R et al (2024) The E3 ubiquitin ligase TRIM21 regulates PGAM5 stability to mediate cardiomyocyte death. Cell Death Dis 15(1):88","journal-title":"Cell Death Dis"},{"issue":"1","key":"11722_CR29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-023-01810-1","volume":"22","author":"J Xu","year":"2023","unstructured":"Xu J, Chen Y, Li W, Wang X, Liu Q, Zhang D et al (2023) Targeting PGAM5 to overcome apoptosis resistance in solid tumors: mechanisms and therapeutic implications. Mol Cancer 22(1):102","journal-title":"Mol Cancer"},{"issue":"30","key":"11722_CR30","doi-asserted-by":"publisher","first-page":"e2202206","DOI":"10.1002\/advs.202202206","volume":"9","author":"C Zhong","year":"2022","unstructured":"Zhong C, Niu Y, Liu W, Yuan Y, Li K, Shi Y et al (2022) S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression. Adv Sci 9(30):e2202206","journal-title":"Adv Sci"},{"issue":"43","key":"11722_CR31","first-page":"50868","volume":"10","author":"PMC Disclaimer | PMC Copyright Notice","year":"2025","unstructured":"PMC Disclaimer | PMC Copyright Notice (2025) Targeting ubiquitin-specific protease 7 (usp7): a pharmacophore-guided drug repurposing and physics-based molecular simulation study. ACS Omega 10(43):50868\u201350881","journal-title":"ACS Omega"},{"issue":"33","key":"11722_CR32","doi-asserted-by":"publisher","first-page":"e202204395","DOI":"10.1002\/anie.202204395","volume":"61","author":"Y Pei","year":"2022","unstructured":"Pei Y, Fu J, Shi Y, Zhang M, Luo G, Luo X et al (2022) Discovery of a potent and selective degrader for USP7. Angew Chem Int Ed 61(33):e202204395","journal-title":"Angew Chem Int Ed"},{"issue":"20","key":"11722_CR33","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai X, Lu L, Deng S, Meng J, Wan C, Huang J et al (2020) USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer. Theranostics 10(20):9332\u20139347","journal-title":"Theranostics"},{"issue":"14","key":"11722_CR34","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.12998\/wjcc.v10.i14.4368","volume":"10","author":"C Wu","year":"2022","unstructured":"Wu C, Feng ML, Jiao TW, Sun MJ (2022) Clinical and prognostic significance of expression of phosphoglycerate mutase family member 5 and Parkin in advanced colorectal cancer. World J Clin Cases 10(14):4368\u20134379","journal-title":"World J Clin Cases"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11722-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:48:59Z","timestamp":1774435739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11722-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11722"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11722-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The views expressed herein are solely those of the authors and do not necessarily represent the official views of Jiangmen Central Hospital, Guangdong Medical University, or the funding agencies. The information presented in this article is for academic and research purposes only and is not intended as medical advice. While the authors and publisher have made every effort to ensure the accuracy and completeness of the information presented, we assume no responsibility for any errors, omissions, or consequences resulting from the use of this content.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"was obtained from all patients. All procedures were approved by the Institutional Research Ethics Committee of the Jiangmen Central Hospital (Approval no. JXY2026016A). All animal experiments were approved by the Institutional Animal Care and Use Committee of Wuyi University (Approval no. Wuyi-2025-065). All methods were carried out in accordance with relevant guidelines and regulations (ARRIVE guidelines and the Declaration of Helsinki).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"536"}}